DESAI VEERAL (Chief Strategy & Dev. Officer) sold 22.3% of their position (79.77K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $2.19M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/25/2022ACC: 0001209191-22-043105
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-79.77K
Net shares
Net seller
$2.19M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
79.77K acquired · 159.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+79.77K
Price / share
$1.00
Trade value
$79.77K
% of position
28.7%
7/21/2022
278.21K→357.98K
Common Stock
Direct
Shares
−79.77K
Price / share
$27.50
Trade value
$2.19M
% of position
22.3%
7/21/2022
357.98K→278.21K
Total
Net shares
+0.00
Net value
-$2.11M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2022 | M · Option Exercise | +79.77K | $1.00 | $79.77K | 28.7% | 278.21K | 357.98K |
| Common Stock Direct | 7/21/2022 | S · Sale | −79.77K | $27.50 | $2.19M | 22.3% | 357.98K | 278.21K |
| Total | +0.00 | -$2.11M | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
79.77K shares
Shares
−79.77K
Strike price
1.00
Held after
57.44K
Exercisable
—
7/21/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock79.77K shares | 7/21/2022 | M · Option Exercise | −79.77K | 1.00 | — | 57.44K |